Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Skolnik

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Sarcoma|August 13, 2016
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue SarcomaAnn Colosia, Shahnaz Khan, Michelle D Hackshaw, et al.
Pediatric Blood & Cancer|June 15, 2011
Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children's Oncology GroupBryan Langholz, Jeffrey M Skolnik, Jeffrey S Barrett, et al.
Pharmacotherapy|September 20, 2011
A reliable and safe method of collecting blood samples from implantable central venous catheters for determination of plasma gentamicin concentrationsJennifer Chen, Sabrina Boodhan, Munira Nanji, et al.
Journal of Clinical Pharmacology|December 21, 2007
Population pharmacokinetic investigation of actinomycin-D in children and young adultsJohn T Mondick, Leonid Gibiansky, Marc R Gastonguay, et al.
Investigational New Drugs|May 23, 2012
A Phase I trial of the kinesin spindle protein (Eg5) inhibitor AZD4877 in patients with solid and lymphoid malignanciesJohn F Gerecitano, Joe J Stephenson, Nancy L Lewis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)Ian W Flinn, Nancy L Bartlett, Kristie A Blum, et al.
The Laryngoscope|May 19, 2023
Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory PapillomatosisTed Mau, Milan R Amin, Peter C Belafsky, et al.
The Laryngoscope|August 9, 2025
DNA Immunotherapy (INO-3107) Results in Long-Term Surgery Reduction in RRPMilan R Amin, Peter C Belafsky, Simon R Best, et al.
Vaccines|February 5, 2020
Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory PapillomatosisCharu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumorsRobert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Sarcoma|August 13, 2016
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue SarcomaAnn Colosia, Shahnaz Khan, Michelle D Hackshaw, et al.
Pediatric Blood & Cancer|June 15, 2011
Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children's Oncology GroupBryan Langholz, Jeffrey M Skolnik, Jeffrey S Barrett, et al.
Pharmacotherapy|September 20, 2011
A reliable and safe method of collecting blood samples from implantable central venous catheters for determination of plasma gentamicin concentrationsJennifer Chen, Sabrina Boodhan, Munira Nanji, et al.
Journal of Clinical Pharmacology|December 21, 2007
Population pharmacokinetic investigation of actinomycin-D in children and young adultsJohn T Mondick, Leonid Gibiansky, Marc R Gastonguay, et al.
Investigational New Drugs|May 23, 2012
A Phase I trial of the kinesin spindle protein (Eg5) inhibitor AZD4877 in patients with solid and lymphoid malignanciesJohn F Gerecitano, Joe J Stephenson, Nancy L Lewis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)Ian W Flinn, Nancy L Bartlett, Kristie A Blum, et al.
The Laryngoscope|May 19, 2023
Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory PapillomatosisTed Mau, Milan R Amin, Peter C Belafsky, et al.
The Laryngoscope|August 9, 2025
DNA Immunotherapy (INO-3107) Results in Long-Term Surgery Reduction in RRPMilan R Amin, Peter C Belafsky, Simon R Best, et al.
Vaccines|February 5, 2020
Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory PapillomatosisCharu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumorsRobert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
Pageof 3